Revenue Update on Editas Medicine, Inc. – Common Stock(NASDAQ:EDIT)

Editas Medicine, Inc. – Common Stock(NASDAQ:EDIT) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Aug 9, 2016. Company reported revenue of $3.39M. Analysts estimated a revenue of $2.44M. Earnings per share were $-0.54. Analysts had estimated an EPS of $-0.54.

In a different note, Jefferies said it Initiates Coverage on Editas Medicine, Inc. – Common Stock, according to a research note issued on Jun 2, 2016. The shares have been rated ‘Hold’ by the firm.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *